I
Indivior Pharmaceuticals Inc
INDV · NASDAQ · Healthcare · 4.9B
Price · close
$36.87
-2.41% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
21.9×
Price / net assetsP/B
—
Enterprise value / EBITDAEV/EBITDA
15.7×
Free cash flow yieldFCF yield
-2.0%
Return on equityROE
-214.3%
Operating margin
21.4%
Net debt / EBITDAbalance-sheet strength
0.5×
Interest coverage
5.9×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.